Subscribe to Newsletter
Subspecialties Glaucoma, Retina

Singing the Blues

For this feature I decided not to follow the brief exactly. This year, we should not just be recognizing and celebrating a single article in a single year; rather, we should be celebrating the amazing increase in quality eye research over time and the exceptional response that has supported it. And we should be celebrating the American Academy of Ophthalmology and the Blue Journal of Ophthalmology for launching Ophthalmology Retina and Ophthalmology Glaucoma, which provide new opportunities for eye researchers to share their work under the imprimatur of ophthalmology.

The American Academy of Ophthalmology and its predecessors have published the original Blue Journal of Ophthalmology and its predecessors for a long time. In 2018, it published volume 125 – the first issue of the Blue Journal of Ophthalmology was published in the 1890s. In the subsequent 125 years, the journal became one of the premier options for publishing top-quality eye research; for instance, most of the landmark publications from the ETDRS study were published in Ophthalmology (1).

It sounds like the Blue Journal of Ophthalmology is on a multigenerational roll. In that case, why would it need to change? The volume of eye research is exploding. That research needs a quality venue and a quality audience to make an impact. Ophthalmology Retina and Ophthalmology Glaucoma provide both that venue and that audience. The venue of Ophthalmology is known for very high-quality peer review and publishing important research papers with a high citation rate.

Ophthalmology Retina was launched in January 2017 and published an issue every other month the first year and every month in 2018, its second year. Ophthalmology Glaucoma was launched in 2018 and published an issue every other month for the first year. These two new ophthalmic journals provide high-quality venues for publishing ophthalmic research, concentrating it into an easily accessible format. That, in my opinion, is worth celebrating.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. 1., “Early Treatment Diabetic Retinopathy Study” (ETDRS) (2006). Available at: Accessed January 1, 2019.
About the Author
Kevin Waltz

Kevin Waltz is President of Ophthalmic Research Consultants, and Chair, Board of Directors for Central American Eye Clinics.

Related Case Studies
Business & Profession Glaucoma
TrabEx Pro: The Next Level in MIGS

| Contributed by MST

Finding Ocular Surface Inflammation

| Contributed by Quidel

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: